On the decision rules of cost-effective treatment for patients with diabetic foot syndrome

被引:6
|
作者
Goulionis, John E. [1 ]
Vozikis, Athanassios [2 ]
Benos, V. K. [1 ]
Nikolakis, D. [1 ]
机构
[1] Univ Piraeus, Dept Stat & Insurance Sci, 80 Karaoli & Dimitriou St, Piraeus 18534, Greece
[2] Univ Piraeus, Dept Econ Sci, Piraeus, Greece
来源
CLINICOECONOMICS AND OUTCOMES RESEARCH | 2010年 / 2卷
关键词
partially observable Markov decision model; diabetic foot syndrome; cost-effectiveness method;
D O I
10.2147/CEOR.S11981
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To. assess the cost-effectiveness of two treatments (medical treatment and amputation) in patients with diabetic foot syndrome, one of the most disabling diabetic complications. Diabetes mellitus is a massive health care problem worldwide with a current prevalence of 150 millions diabetic cases, estimated to increase to 300 million cases in 2025. Methods: Integrating medical knowledge and advances into the clinical setting is often difficult due to the complexity of the algorithms and protocols. Clinical decision support systems assist the clinician in applying new information to patient care through the analysis of patient-specific clinical variables. We require strategic decision support to analyze the cost-effectiveness of these programs compared to the status quo. We provide a simple partially observable Markov model to investigate that issue, and we propose an heuristic algorithm to find the best policy of intervention. Results: This study assesses the potential cost-effectiveness of two alternative treatment interventions in patients with diabetic foot syndrome. The implementation of the heuristic algorithm solution will assist doctors in clinical decision making, and health care organizations in evaluating medication choices for effective treatment. Finally, our study reveals that treatment programs are highly cost-effective for patients at high risk of diabetic foot ulcers and lower extremity amputations.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 50 条
  • [31] Case report: Successful treatment of a diabetic foot syndrome with hyaluronidase infusion therapy
    Pfuetzner, A.
    Segiet, T.
    Hanna, M.
    Kalasauske, D.
    Sachsenheimer, D.
    DIABETES STOFFWECHSEL UND HERZ, 2023, 32 (05): : 240 - 244
  • [32] Randomized Double-blind Cost-effectiveness Comparison of Two 10% Urea Creams in Patients with Diabetic Foot Syndrome
    Ramirez, Sol Tejeda
    Tardaguila-Garcia, Aroa
    Lopez-Moral, Mateo
    Sanz-Corbalan, Irene
    Garcia-Madrid, Marta
    Lazaro-Martinez, Jose Luis
    ADVANCES IN SKIN & WOUND CARE, 2024, 37 (05) : 1 - 7
  • [33] Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome
    Giuseppe Seghieri
    Laura Policardo
    Elisa Gualdani
    Roberto Anichini
    Paolo Francesconi
    Acta Diabetologica, 2019, 56 : 561 - 567
  • [34] Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome
    Seghieri, Giuseppe
    Policardo, Laura
    Gualdani, Elisa
    Anichini, Roberto
    Francesconi, Paolo
    ACTA DIABETOLOGICA, 2019, 56 (05) : 561 - 567
  • [35] Possibilities of combined surgical treatment of pyonecrotic lesions in the neuroischemic form of diabetic foot syndrome
    Mitish, V. A.
    Eroshkin, I. A.
    Galstyan, G. R.
    Doronina, L. P.
    Paskhalova, Y. S.
    Eroshenko, A. V.
    Dedov, I. I.
    DIABETES MELLITUS, 2009, 12 (01): : 8 - 13
  • [36] Personality and relational determinants of following physicians' instructions in patients with mixed diabetic foot syndrome
    Stanisic, Michal Goran
    Rzepa, Teresa
    Kucun, Magdalena
    Cierpialkowska, Lidia
    ACTA ANGIOLOGICA, 2015, 21 (03): : 83 - 86
  • [37] Ultrasonic Influence on Biofilm-Forming Bacteria Isolated in Patients with Diabetic Foot Syndrome
    Abdulina, Galiya
    Akhmetova, Saule
    Nikolayeva, Antonina
    Sraulkanova, Baiyan
    Sambilova, Nataliya
    Moraru, Dan
    Chesca, Antonella
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 151 - 155
  • [38] The Morphological Rationality for the Expediency of Topical Application of Silver Sulfathiazole in Patients with Diabetic Foot Syndrome
    Kalinichenko, Aleksej P.
    Hryvenko, Serhiy H.
    Umerov, Ervin E.
    Uzbekova, Leyla D.
    Usmanova, Tamila E.
    Izosimov, Vladimir V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (03) : 404 - 408
  • [39] Influence of Pain on the Quality of Life and Disease Acceptance in Patients with Complicated Diabetic Foot Syndrome
    Krzeminska, Sylwia
    Kostka, Anna
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1295 - 1303
  • [40] Prevention of foot ulcers recurrence in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials for the development of the italian guidelines for the treatment of diabetic foot syndrome
    Da Ros, Roberto
    Volpe, Antonio
    Bordieri, Corrado
    Tramonta, Rodolfo
    Bernetti, Andrea
    Scatena, Alessia
    Monge, Luca
    Ragghianti, Benedetta
    Silverii, Antonio
    Uccioli, Luigi
    Vermigli, Cristiana
    Monami, Matteo
    Miranda, Cesare
    ACTA DIABETOLOGICA, 2024, : 1363 - 1373